To overcome the poor efficacy of Ad-mAFP-DC towards pre-established HCC, Ad-CD40L- DC were injected i.t. five days after Ad-mAFP-DC-vaccination. The gene discussed is CD40LG; the disease is hepatocellular carcinoma.